• Ultima’s ppmSeq Pushes Sequencing to New Levels of Accuracy

    Aug 28 | Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays. More

  • Follow the Money: Rheumatoid Arthritis Therapy, Novel Next-Gen Biosensor, More

    Aug 27 | Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more. More

  • BioMed X, Novo Nordisk Collaboration, 10x Genomics Launches Platform Addition, More

    Aug 26 | Bio-IT World| BioMed X announced the launch of a new collaboration with Novo Nordisk; 10x Genomics launched Xenium Protein, a new addition to its Xenium Spatial platform; and more. More

  • Bioprocessing Summit Honors LISURE as Best of Show Winner

    Aug 21 | Bio-IT World | During this week’s Bioprocessing Summit in Boston, M++ UltraPilot from LISURE was named the winner of the Best of Show People’s Choice Award competition. Other finalists and their products were also named and featured. More

  • Family-Based Genomics Benchmark Promises More Accurate Variant Detection

    Aug 20 | Bio-IT World | A multi-generational family tree is helping researchers dramatically improve the accuracy of genomic variant calling, according to a new study published in Nature Methods. The research, led by scientists at Pacific Biosciences, introduces a comprehensive benchmarking dataset that could reshape how genomic technologies are trained and validated. More

  • Nature’s Most Promising Bioactives to Speed Up Evidence-Based Drug Discovery

    Aug 19 | Bio-IT World | Natural products and medicines mimicking substances found in nature have been used clinically for well over 100 years and could help remedy what ails today’s alarmingly long and relatively unproductive drug discovery process. Since bioactive substances from natural resources have a track record of use against disease, they are a compelling starting point for evidence-based discovery of novel human therapies. More

  • Open-Source Medical Device Platform Aims to Accelerate Time to Market

    Aug 14 | Bio-IT World | San Francisco biotech Openwater is pioneering a multi-purpose platform approach to medical device development, combining infrared light and low-intensity focused ultrasound technologies to create what CEO Aaron Timm describes as the "smartphone" of medical devices. More

  • AI-Powered Cell Mapping Platform Accelerates Biotech Research and Drug Development

    Aug 13 | Bio-IT World | Virginia Commonwealth University researchers have developed an artificial intelligence platform that could dramatically accelerate biotech research by solving one of the field's most computationally intensive challenges—rapidly identifying and analyzing distinct cell types in complex biological tissues. More

  • AI in Medicine Making and Healthcare: Finding the Balance

    Aug 12 | Bio-IT World | The pharma industry excels at collaborating with startup companies and scaling up the production of drugs and biologics, but they may be missing the big-picture perspective of the U.S. government as well as some of the cutting-edge research happening within academia. It’s a problematic norm that needs addressing if artificial intelligence (AI) is to benefit drug discovery and diagnostics as well as healthcare delivery in terms of safety, equity, and effectiveness. More

  • Russia Targets National Database of 1 Million Genomes by 2030

    Aug 07 | Bio-IT World | Russia plans to significantly expand its national database of genetic information by 2030 according to a recent decree approved by the Russian government. As part of the plans, the volume of the already existing database will be increased by 35 times and reach 35 petabytes by 2030. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!